The global market for pharmaceutical analytical testing outsourcing is characterized by the presence of many global, regional, and local vendors. The market is highly competitive with all the players competing to gain the market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for vendors to provide cost-efficient and high-quality services, to survive and succeed in an intensely competitive market environment.
The growth of market vendors is dependent on market conditions, government support, and industry development. Thus, vendors should focus on expanding geographically and improving their products. Although international players are dominating the market, regional and foreign players with small market shares also have a presence. The international players are likely to strengthen their presence through acquisitions during the forecast period.
Charles River is a contract research organization (CRO), engaged in providing essential products and services for accelerating drug development. The company is a global provider of solutions, which accelerate the drug discovery and development process, comprising research models and associated services, and outsourced preclinical services. The company is a significant player in the market due to global reach and strong brand presence.
West Pharmaceutical Services, Inc. is another important company in the global pharmaceutical analytical testing outsourcing market.
West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the US, Germany, France, other European countries, and internationally. The company operates through two segments, namely, proprietary products and contract-manufactured products. The contract-manufactured products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves the pharmaceutical, diagnostic, and medical device companies.
Bargaining Power of Suppliers
The suppliers in the pharmaceutical analytical testing outsourcing market are the developers and manufacturers. There is a high number of suppliers in the pharmaceutical analytical testing outsourcing market thus leading to a high amount of bargaining power in the market. Switching cost of these suppliers is also high as suppliers tend to enter long-term associations with the major companies. However, Asia-Pacific countries are consisting of a large number of suppliers which offer pharmaceutical analytical testing outsourcing at a relatively less price. Due to this reason of high bargaining power of suppliers the profit potential of the global pharmaceutical analytical testing outsourcing market is reduced.
Bargaining Power of Buyers
The bargaining power of buyers is moderate to high in the global pharmaceutical analytical testing outsourcing market. The market has a large number of buyers comprising of healthcare facilities like pharmaceutical firms, and biotechnological industries. The buyers in the pharmaceutical analytical testing outsourcing market hold a certain degree of power over market players because of the high concentration of the buyers.
Threat of New Entrants
The threat of new entrants is moderate in the pharmaceutical analytical testing outsourcing market. Any pharmaceutical analytical testing outsourcing company trying to enter the market is required to accept or abide by the mandatory regulatory standards. The pharmaceutical analytical testing outsourcing market is also characterized by a reasonable degree of brand loyalty where establishing a brand name is difficult for newcomers. However, the cost involved in the initial setup is comparatively high which does not comfort the new entrants to enter the market easily.
Threat of Substitutes
The threat of substitutes in the pharmaceutical analytical testing outsourcing market is low as there is hardly any alternative for bioanalytical testing services.
Intensity of Rivalry
The degree of competition in the pharmaceutical analytical testing outsourcing market is high. The restrained degree of services differentiation among existing players increases the intensity of rivalry in the market. pharmaceutical analytical testing outsourcing companies are trying to develop less expensive pharmaceutical analytical testing consumable and instruments to make procedures more affordable in developing regions. To overcome the competition, players are engaged in developing processes to lower their manufacturing cost.
